Effects of cinnarizine, a calcium antagonist that produces human parkinsonism, in parkin knock out mice

Neuropharmacology

Volumn 49, Issue 2, 2005, Pages 208-219

  Serrano, A ^a   Menendez J ^b   Casarejos, M J ^b   Solano, R M ^b   Gallego, E ^a   Sanchez M ^a   Mena, M A ^b   Garcia De Yebenes J ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Apoptosis; Astrocytes; Calcium antagonist; Dopamine neurons; Dyskinesias; Glutathione; Locomotor activity; Microglia; Park 2 gene; Parkinson's disease

Indexed keywords

BETA TUBULIN; CALCIUM ANTAGONIST; CELL MARKER; CINNARIZINE; DOPAMINE; DOPAMINE RECEPTOR; FREE RADICAL; GLUTATHIONE; PARKIN; TYROSINE 3 MONOOXYGENASE;

ALOPECIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; DOPAMINE RELEASE; DYSKINESIA; FEMALE; INFLAMMATION; KNOCKOUT MOUSE; MICROGLIA; MOTOR DYSFUNCTION; MOUSE; MUTAGENESIS; NEUROCHEMISTRY; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PARKINSONISM; PRIORITY JOURNAL; RECEPTOR BLOCKING; WILD TYPE;

ANALYSIS OF VARIANCE; ANIMALS; ANTIGENS, DIFFERENTIATION; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; BEHAVIOR, ANIMAL; BIOGENIC MONOAMINES; BLOTTING, WESTERN; BODY WEIGHT; BRAIN CHEMISTRY; CALCIUM CHANNEL BLOCKERS; CHROMATOGRAPHY; CINNARIZINE; DRINKING; EATING; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTATHIONE; HUMANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; PARKINSONIAN DISORDERS; PROTO-ONCOGENE PROTEINS C-BCL-2; TYROSINE 3-MONOOXYGENASE; UBIQUITIN-PROTEIN LIGASES;

EID: 21644446776     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2005.03.003     Document Type: Article

References (32)

1. N. Abbas, C.B. Lucking, S. Ricard, A. Durr, V. Bonifati, G. De Michele, S. Bouley, J.R. Vaughan, T. Gasser, R. Marconi, E. Broussolle, C. Brefel-Courbon, B.S. Harhangi, B.A. Oostra, E. Fabrizio, G.A. Bohme, L. Pradier, N.W. Wood, A. Filla, G. Meco, P. Denefle, Y. Agid, and A. Brice A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease Human Molecular Genetics 8 1999 567 574
2. C. Alves da Costa, E. Masliah, and F. Checler β-Synuclein displays an antiapoptotic p53-dependent phenotype and protects neurons from 6-hydroxydopamine-induced caspase 3 activation Journal of Biological Chemistry 39 2003 37330 37335
3. A. Carlsson, and M. Lindqvist Effect of ethanol on the hydroxylation of tyrosine and tryptophan in rat brain in vivo Journal of Pharmacy and Pharmacology 25 1973 437 440
4. F. Darios, O. Corti, C.B. Lucking, C. Hampe, M.P. Muriel, N. Abbas, W.J. Gu, E.C. Hirsch, T. Rooney, M. Ruberg, and A. Brice Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death Human Molecular Genetics 12 2003 517 526
5. P.J. Garcia-Ruiz, M.A. Mena, N. Penafiel, and J.G. De Yebenes Cinnarizine-induced parkinsonism in primates Clinical Neuropharmacology 15 1992 152 154
6. P.J. Garcia-Ruiz, J. Garcia de Yebenes, F.J. Jimenez-Jimenez, A. Vazquez, D. Garcia Urra, and B. Morales Parkinsonism associated with calcium channel blockers: a prospective follow-up study Clinical Neuropharmacology 15 1992 19 26
7. O.W. Griffith Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine Analytical Biochemistry 106 1980 207 212
8. J. Hardy, M.R. Cookson, and A. Singleton Genes and parkinsonism Lancet Neurology 2 2003 221 228
9. J. Hoenicka, L. Vidal, B. Morales, I. Ampuero, F.J. Jimenez-Jimenez, J. Berciano, T. del Ser, A. Jimenez, P.G. Ruiz, and J.G. de Yebenes Molecular findings in familial Parkinson disease in Spain Archives of Neurology 59 2002 966 970
10. J.M. Itier, P. Ibanez, M.A. Mena, N. Abbas, C. Cohen-Salmon, G.A. Bohme, M. Laville, J. Pratt, O. Corti, L. Pradier, G. Ret, C. Joubert, M. Periquet, F. Araujo, J. Negroni, M.J. Casarejos, S. Canals, R. Solano, A. Serrano, E. Gallego, M. Sanchez, P. Denefle, J. Benavides, G. Tremp, T.A. Rooney, A. Brice, and J. Garcia de Yebenes Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse Human Molecular Genetics 12 2003 2277 2291
11. F.J. Jimenez-Jimenez, P.J. Garcia-Ruiz, and J.A. Molina Drug-induced movement disorders Drug Safety 16 1997 180 204
12. C. Klein, P.P. Pramstaller, B. Kis, C.C. Page, M. Kann, J. Leung, H. Woodward, C.C. Castellan, M. Scherer, P. Vieregge, X.O. Breakefield, P.L. Kramer, and L.J. Ozelius Parkin deletions in a family with adult-onset, tremor-dominant parkinsonism: expanding the phenotype Annals of Neurology 48 2000 65 71
13. M. Lam, M.B. Bhat, G. Nunez, J. Ma, and C.W. Distelhorst Regulation of Bcl-xl channel activity by calcium Journal of Biological Chemistry 273 1998 17307 17310
14. + fluxes Proceedings of the National Academy of Sciences, USA 91 1994 6569 6573
15. M.D. Ledesma, C. Galvan, B. Hellias, C. Dotti, and P.H. Jensen Astrocytic but not neuronal increased expression and redistribution of parkin during unfolded protein stress Journal of Neurochemistry 83 2002 1431 1440
16. C.B. Lucking, A. Durr, V. Bonifati, J. Vaughan, G. De Michele, T. Gasser, B.S. Harhangi, G. Meco, P. Denefle, N.W. Wood, Y. Agid, and A. Brice Association between early-onset Parkinson's disease and mutations in the parkin gene French Parkinson's Disease Genetics Study Group New England Journal of Medicine 342 2000 1560 1567
17. J.F. Marti-Masso, and J.J. Poza Cinnarizine-induced parkinsonism: ten years later Movement Disorders 13 1998 453 456
18. M.A. Mena, M.J. Casarejos, A. Bonin, J.A. Ramos, and J. Garcia Yebenes Effects of dibutyryl cyclic AMP and retinoic acid on the differentiation of dopamine neurons: prevention of cell death by dibutyryl cyclic AMP Journal of Neurochemistry 65 1995 2612 2620
19. M.A. Mena, M.J. Garcia de Yebenes, C. Tabernero, M.J. Casarejos, B. Pardo, and J. Garcia de Yebenes Effects of calcium antagonists on the dopamine system Clinical Neuropharmacology 18 1995 410 426
20. M.A. Mena, S. de Bernardo, M.J. Casarejos, S. Canals, and E. Rodríguez-Martín The role of astroglia on the survival of dopamine neurons Molecular Neurobiology 25 2002 245 263
21. N.C. Myrianthopoulos, F.N. Waldrop, and B.L. Vincent A repeat study of hereditary predisposition in drug induced parkinsonism A. Barbeau J.R. Brunette Progress in Neurogenetics vol. 175 1967 486 491 Amsterdam
22. A. Negrotti, and S. Calzetti Cinnarizine-induced parkinsonism: ten years later Movement Disorders 14 1999 534 535
23. J.J. Palacino, D. Sagi, M.S. Goldberg, S. Krauss, C. Motz, M. Wacker, J. Klose, and J. Shen Mitochondrial dysfunction and oxidative damage in parkin-deficient mice Journal of Biological Chemistry 279 2004 18614 18622
24. Y. Ren, J. Zhao, and J. Feng Parkin binds to alpha/beta tubulin and increases their ubiquitination and degradation Journal of Neuroscience 23 2003 3316 3324
25. L.M. Sayre, F.J. Wang, P.K. Arora, N.J. Riachi, S.I. Harik, and C.L. Hoppel Dopaminergic neurotoxicity in vivo and inhibition of mitochondrial respiration in vitro by possible endogenous pyridinium-like substances Journal of Neurochemistry 57 1991 2106 2115
26. D. Tarsy Neuroleptic induced movement disorders N.P. Quinn P.J. Jenner Disorders of Movement: Clinical, Pharmacological and Physiological Aspects 1989 Academic Press London 361 394
27. W.G. Tatton, R. Chalmers-Redman, D. Brown, and N. Tatton Apoptosis in Parkinsońs disease: signals for neuronal degradation Annals of Neurology 53 Suppl. 3 2003 S61 S72
28. +-ATPase in catecholamine storage vesicles Neuropharmacology 38 1999 879 882
29. F. Tietze Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues Annals of Biochemistry 27 1969 502 522
30. J.A. Van Gerpen Drug-induced parkinsonism Neurologist 8 2002 363 370
31. K. Veitch, and L. Hue Flunarizine and cinnarizine inhibit mitochondrial complexes I and II: possible implication for parkinsonism Molecular Pharmacology 45 1994 158 163
32. J.E. Walker The NADH:ubiquinone oxidoreductase (complex I) of respiratory chains Quarterly Reviews of Biophysics 25 1992 253 324